Cantor Fitzgerald initiated coverage on shares of Anteris Technologies Global (NASDAQ:AVR - Free Report) in a research report sent to investors on Tuesday morning, MarketBeat Ratings reports. The firm issued an overweight rating and a $9.00 target price on the stock.
Separately, Barclays started coverage on Anteris Technologies Global in a research note on Tuesday. They issued an "overweight" rating and a $22.00 price target for the company.
View Our Latest Report on Anteris Technologies Global
Anteris Technologies Global Stock Performance
AVR stock traded up $0.14 during midday trading on Tuesday, hitting $5.75. 421,728 shares of the stock traded hands, compared to its average volume of 176,407. Anteris Technologies Global has a 1-year low of $5.10 and a 1-year high of $6.00.
Anteris Technologies Global Company Profile
(
Get Free Report)
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
Before you consider Anteris Technologies Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.
While Anteris Technologies Global currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
